Increased CD36 and FABP4 immunostaining were detected in kidney specimens from diabetic patients vs. those without diabetes (Figure 8a and Figure 8b, respectively) and confirmed via quantitation of immunostaining (Figure 8c and Figure 8d), respectively). This evidence concerns the gene CD36 and diabetes mellitus.